Cefazolin Sodium for Injection (0.5g) and Ceftazidime for Injection (1.0g) both will be enrolled in the latest No.5 round of national drug centralized procurement.
During the procurement period, medical facilities will give priority to using products that have won the bid, and ensure the proposed procurement quantity. The selection of cefazolin and ceftazidime of Gosun will further expand the sales of the above-mentioned products, enhance market competitiveness, and help reduce the impact of policies such as centralized drug procurement on the anti-infection business.
